Teneligliptin improves metabolic abnormalities in a mouse model of postmenopausal obesity

27 Oct 2015


Sameshema et al. demonstrate the therapeutic effects of the novel DPP4 inhibitor, teneligliptin, on the features of postmenopausal obesity in mice.

Journal of Endocrinology


Share this story